Author:
Shan Jian-zhen,Xuan Yan-yan,Zhang Qi,Huang Jian-jin
Funder
Zhejiang Science and Technology Research Program of China
Publisher
Zhejiang University Press
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Veterinary,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference32 articles.
1. Bai, X.L., Zhang, Q., Ye, L.Y., et al., 2014. Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas. Mol. Cancer Ther., 13(8):2062–2072. http//dx.doi.org/10.1158/1535-7163.MCT-13-0800
2. Bellamy, W.T., 1996. P-glycoproteins and multidrug resistance. Annu. Rev. Pharmacol. Toxicol., 36:161–183.
3. Cao, Y., Eble, J.M., Moon, E., et al., 2013. Tumor cells upregulate normoxic HIF-1a in response to doxorubicin. Cancer Res., 73(20):6230–6242. http//dx.doi.org/10.1158/0008-5472.CAN-12-1345
4. Chen, J., Ding, Z., Peng, Y., 2014. HIF-1a inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein. PLOS ONE, 9(6):e98882. http//dx.doi.org/10.1371/journal.pone.0098882
5. Chen, W., Zheng, R., Baade, P.D., 2016. Cancer statistics in China, 2015. CA: Cancer J. Clin., 66(2):115–132. http//dx.doi.org/10.3322/caac.21338
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献